Strokecopilot: A Precision Medicine Tool in the Stroke Emergency

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Ischemic stroke or cerebral infarction (CI) is an immediate emergency affecting approximately 100,000 - 150,000 patients each year in France and is managed in the neurovascular intensive care unit (NICU). Recanalization treatments can prevent disability, but patients must be carefully selected. Knowledge in this field is evolving rapidly, which tends to make management more complex and personalized. In addition, the permanence of thrombolysis channels involves neurologists of all expertise. Decision support tools are desirable to enable precision medicine in stroke. Strokecopilot is a web application developed by the principal investigator. Its algorithm contextualizes the patient in a set of evidence-based medicine references (recommendations and clinical trials) and gives the result of their cross-referencing to the user to indicate theoretical indications for intravenous thrombolysis and mechanical thrombectomy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \- Adult patient (\>18 years old) admitted to the thrombolysis unit of the University Hospital of Strasbourg from January 01, 2017 to December 31, 2021

Locations
Other Locations
France
Service : Unité Neurovasculaire - CHU de Strasbourg - France
RECRUITING
Strasbourg
Contact Information
Primary
Valérie WOLFF, MD, PhD
valerie.wolff@chru-strasbourg.fr
33 3 88 12 85 19
Time Frame
Start Date: 2022-05-10
Estimated Completion Date: 2023-12-31
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Strasbourg, France

This content was sourced from clinicaltrials.gov